Alector (ALEC) Net Cash Flow (2018 - 2026)
Alector (ALEC) reported Net Cash Flow of $11.2 million for Q1 2026, up 125.36% year-over-year from $5.0 million in Q1 2025, and up 204.29% quarter-over-quarter from -$10.7 million in Q4 2025.
Alector (ALEC) Net Cash Flow (2018 - 2026) Analysis & Trends
Alector (ALEC) has 9 years of Net Cash Flow data on file, last reported at $11.2 million in Q1 2026.
- Net Cash Flow for Q1 2026 came in at $11.2 million, up 125.36% year-over-year; the trailing twelve-month figure through Mar 2026 was $39.0 million (up 213.74% YoY), and the FY2025 annual result was $32.8 million, up 179.5% from the prior year.
- Net Cash Flow improved to $11.2 million in Q1 2026 per ALEC's latest filing, from -$10.7 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $125.5 million in Q1 2022 and troughed at -$282.4 million in Q2 2022.
- A 5-year average of -$14.8 million and a median of -$3.8 million in 2024 frame the typical range for Net Cash Flow.
- The sharpest annual moves came in 2022 and 2025: Net Cash Flow sank 1981.11% in 2022, then surged 405.53% in 2025.
- A 5-year view of Net Cash Flow shows it stood at -$29.9 million in 2022, then climbed by 8.36% to -$27.4 million in 2023, then soared by 86.0% to -$3.8 million in 2024, then sank by 178.82% to -$10.7 million in 2025, then surged by 204.29% to $11.2 million in 2026.
- Business Quant data shows ALEC's Net Cash Flow at $11.2 million in Q1 2026, -$10.7 million in Q4 2025, and $31.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 625.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 457.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 664,983.53 |
| 10 | Alector | 193.53 Mn | -12.98 Mn | - | 11.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.16 Mn |
| Mar 31, 2026 | 11.16 Mn |
| Dec 31, 2025 | -10.70 Mn |
| Dec 31, 2025 | -10.70 Mn |
| Sep 30, 2025 | 31.73 Mn |
| Sep 30, 2025 | 31.73 Mn |
| Jun 30, 2025 | 6.80 Mn |
| Jun 30, 2025 | 6.80 Mn |
| Mar 31, 2025 | 4.95 Mn |
| Mar 31, 2025 | 4.95 Mn |
| Dec 31, 2024 | -3.84 Mn |
| Dec 31, 2024 | -3.84 Mn |
| Sep 30, 2024 | -10.39 Mn |
| Sep 30, 2024 | -10.39 Mn |
| Jun 30, 2024 | -25.01 Mn |
| Jun 30, 2024 | -25.01 Mn |
| Mar 31, 2024 | -2.00 Mn |
| Mar 31, 2024 | -2.00 Mn |
| Dec 31, 2023 | -27.41 Mn |
| Dec 31, 2023 | -27.41 Mn |